HMG1 protein inhibits the translesion synthesis of the major DNA cisplatin adduct by cell extracts

Journal of Molecular Biology

Volumn 270, Issue 4, 1997, Pages 539-543

  Hoffmann, Jean Sébastien ^a   Locker, Daniel ^b   Villani, Giuseppe ^a   Leng, Marc ^a  

^a CNRS   (France)

^b CENTRE DE BIOPHYSIQUE MOLÉCULAIRE   (France)

Author keywords

Cisplatin; DNA replication; HMG proteins; Translesion synthesis

Indexed keywords

CELL EXTRACT; CISPLATIN; HIGH MOBILITY GROUP PROTEIN; SYNTHETIC DNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA ADDUCT; DNA CROSS LINKING; DNA REPLICATION; DNA SYNTHESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING;

ANIMALIA; EUKARYOTA;

EID: 0031586219     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1997.1143     Document Type: Editorial

References (30)

1. Berners-Price S. J., Corazza A., Guo Z., Barnham K. J., Sadler P. J., Ohyama Y., Leng M., Locker D. Structural transitions of a GG-platinated DNA duplex induced by pH, temperature and box A of high-mobility-group protein 1. Eur. J. Biochem. 243:1997;782-791.
2. Bianchi M. E. Production of functional rat HMG I protein in Escherichia coli. Gene. 104:1991;271-275.
3. Bianchi M. E. The HMG box domain. DNA-protein: structural interactions. 1995;Oxford University Press, Oxford.
4. Bianchi M. E., Falciola L., Ferrari S., Lilley D. M. J. The DNA binding site of HMG 1 protein is composed of two similar segments (HMG boxes), both of which have counterparts in other eukaryotic regulatory proteins. EMBO J. 11:1992;1055-1063.
5. Brown S. J., Kellet P. J., Lippard S. J. Ixr1, a yeast protein that binds to platinated DNA and confers sensitivity to cisplatin. Science. 261:1993;603-605.
6. Bustin M., Reeves R. High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. Prog. Nucl. Acid Res. Mol. Biol. 54:1996;35-100.
7. Churchill M. E. A., Jones D. N. M., Glaser T., Hefner H., Searles M. A., Travers A. A. HMG-D is an architecture-specific protein that preferentially binds to DNA containing the dinucleotide TG. EMBO J. 14:1995;1264-1275.
8. Duckett D. R., Drummond J. T., Murchie A. I. H., Reardon J. T., Sancar A., Lilley D. M., Modrich P. Human MutSα recognizes damaged DNA base pairs containing O6-methylguanine, O4-methylthymine, or the cisplatin-d(GpG) adduct. Proc. Natl Acad. Sci. USA. 93:1996;6443-6447.
9. Grosschedl R., Giese K., Pagel J. HMG domain proteins: architectural elements in the assembly of nucleoprotein structures. Trends Genet. 10:1994;94-100.
10. Hoffmann J. S., Pillaire M. J., Lesca C., Burnouf D., Fuchs R. P. P., Defais M., Villani G. Fork-like DNA templates support bypass replication of lesions that block DNA synthesis on single-stranded templates. Proc. Natl Acad. Sci. USA. 93:1996;13766-13769.
11. Huang J. C., Zamble D. B., Reardon J. T., Lippard S. J., Sancar A. HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease. Proc. Natl Acad. Sci. USA. 91:1994;10394-10398.
12. Hughes E. N., Engelsberg M. A., Billings P. C. Purification of nuclear proteins that bind to cisplatin-damaged DNA. Identification with high mobility group proteins 1 and 2. J. Biol. Chem. 267:1992;13520-13527.
13. King C. Y., Weiss M. A. The SRY high-mobility-group box recognizes DNA by partial intercalation in the minor groove: a topological mechanism of sequence specificity. Proc. Natl. Acad. Sci. USA. 90:1993;11990-11994.
14. Lepre C. A., Lippard S. J. Interaction of platinum antitumor compounds with DNA. Eckstein F., Lilley D. M. J. Nucleic Acids and Molecular Biology. 1990;Springer-Verlag, Berlin.
15. Locker D., Decoville M., Maurizot J. C., Bianchi M. E., Leng M. Interaction between cisplatin-modified DNA and the HMG boxes of HMG 1: DNase I footprinting and circular dichroism. J. Mol. Biol. 246:1995;243-247.
16. Loehrer P. J., Einhorn K. H. Diagnosis and treatment : cisplatin. Ann Intern. Med. 100:1984;704-713.
17. Love J. J., Li X. A., Case D. A., Giese K., Grosschedl R., Wright P. E. Structural basis for DNA bending by the architectural transcription factor LEF-1. Nature. 376:1995;791-795.
18. McA'Nulty M. M., Lippard S. Consequences of HMG-Domain protein binding to cisplatin-modified DNA. Eckstein F., Lilley D. M. J. Nucleic Acids and Molecular Biology. 1995;Springer-Verlag, Berlin.
19. McA'Nulty M. M., Lippard S. The HMG-domain protein Ixr1 blocks excision repair of cisplatin-DNA adducts in yeast. Mutat Res. 362:1996;75-86.
20. Mello J. A., Acharya S., Fishel R., Essigmann J. The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin. Chem. Biol. 3:1996;579-589.
21. Moggs J. G., Szymkowski D. E., Yamada M., Karran P., Wood R. D. Differential human nucleotide excision repair of paired and mispaired cisplatin-DNA adducts. Nucl. Acids Res. 25:1997;480-490.
22. Pil P. M., Lippard S. J. Specific binding of chromosomal protein HMG 1 to DNA damaged by the anticancer drug cisplatin. Science. 256:1992;234-237.
23. Read C. M., Cary P. D., Crane-Robinson C., Driscoll P. C., Norman D G. Solution structure of a DNA-binding domain from HMG 1. Nucl. Acids Res. 21:1993;3427-3436.
24. Sip M., Leng M. DNA, cisplatinum and intercalators: catalytic activity of the DNA double helix. Eckstein F., Lilley D. M. J. Nucleic Acids and Molecular Biology. 1990;Springer-Verlag, Berlin.
25. Treiber D. K., Zhai X., Jantzen H., Essigmann J. M. Cisplatin-DNA adducts are molecular decoys for the ribosomal RNA transcription factor hUBF (human upstream binding factor. Proc. Natl Acad. Sci., USA. 91:1994;5672-5676.
26. Travers A. A., Ner S. S., Churchill M. E. A. DNA chaperones: a solution to a persistence problem? Cell. 77:1994;167-169.
27. Yamada M., O'Reagan E., Brown R., Karran P. Selective recognition of cisplatin-DNA adduct by human mismatch repair proteins. Nucl. Acids Res. 25:1997;491-495.
28. Weir H. M., Kraulis P. J., Hill C. S., Raine A. R. C., Laue E. D., Thomas J. Structure of the HMG box motif in the B-domain of HMG 1. EMBO J. 12:1993;1311-1319.
29. Werner M. H., Ruth J. R., Gronenborn A. M., Clore G. M. Molecular basis of human 46X,Y sex reversal revealed from the three-dimensional solution structure of the human SRY-DNA complex. Cell. 81:1995;705-714.
30. Zamble D. B., Mu D., Reardon J. T., Sancar A., Lippard S. J. Repair of cisplatin-DNA adducts by the mammalian excision nuclease. Biochemistry. 35:1996;10004-10013.